Arthritis & Rheumatism

Xeljanz approved for rheumatoid arthritis

(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.

Neuroscience

Antibodies as 'messengers' in the nervous system

Antibodies are able to activate human nerve cells within milliseconds and hence modify their function—that is the surprising conclusion of a study carried out at Human Biology at the Technical University of Munich (TUM). ...

Medical research

New mechanism for male infertility discovered

A new study led from Karolinska Institutet in Sweden links male infertility to autoimmune prostatic inflammation. The findings are published in the journal Science Translational Medicine.

Arthritis & Rheumatism

Protein that triggers juvenile arthritis identified

Juvenile idiopathic arthritis, or JIA, is the most common form of childhood arthritis. It appears to be an autoimmune disease, caused by antibodies attacking certain proteins in a person's own tissue. But no "autoantigens"—the ...

Genetics

Did evolution give us inflammatory disease?

In new research published on March 21, 2013 in the online issue of The American Journal of Human Genetics, researchers from Brigham and Women's Hospital (BWH) demonstrate that some variants in our genes that contribute to ...

page 3 from 4